SCHEMBL7770898

SCHEMBL7770898

CCCCCCCCCCCC(=O)OC(CNC(C)C)COc1cccc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2E1 Q9Y466 5/20 0.60
▸ CYP2D6 P10635 5/20 0.56
▸ ADRB2 P07550 4/20 0.56
▸ ADRB1 P08588 4/20 0.56
▸ SIGMAR1 Q99720 4/20 0.56
▸ CYP1A2 P05177 3/20 0.56
▸ SLC6A4 P31645 3/20 0.56
▸ HTR2B P41595 3/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ ADRB3 P13945 3/20 0.56
▸ HTR2A P28223 3/20 0.56
▸ HTR2C P28335 3/20 0.56
▸ HTR6 P50406 3/20 0.56
▸ HTR1B P28222 3/20 0.56
▸ SCN1A P35498 2/20 0.56
▸ SLC10A1 Q14973 2/20 0.56
▸ SCN2A Q99250 2/20 0.56
▸ SCN3A Q9NY46 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ HTR1A P08908 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11025259 1.00 NR2E1 (0.60) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL14107149 0.96 NR2E1 (0.63) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL2796170 0.94 NR2E1 (0.54) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL22354579 0.93 NR2E1 (0.67) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL25587771 0.87 NR2E1 (0.68) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL13265580 0.85 NR2E1 (0.57) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL3259801 0.84 NR2E1 (0.55) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
SCHEMBL10782382 0.83 ADRB2 (0.56) CYP2D6ADRB2ADRB1CYP1A2SLC6A4
Stearic Acid SCHEMBL11025256 0.82 ADRB2 (0.71) NR2E1CYP2D6ADRB2ADRB1SIGMAR1
Propranolol SCHEMBL7770896 0.82 ADRB2 (0.71) NR2E1CYP2D6ADRB2ADRB1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2001508027-A — — 2001-06-19 — — JP claimed
EP-1024833-A1 Pharmaceutical composition containing acid addition salt of basic drug FARMARC NEDERLAND B.V. (NL) 2000-08-09 — — EP claimed
WO-1998002187-A1 PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG FARMARC NEDERLAND B.V. (NL) 1998-01-22 — — WO claimed
US-6255502-B1 DRUG DELIVERY THROUGH SKIN, INTESTINAL, ORAL, NASAL, AND RECTAL MUCOSA ENHANCED BY FORMING INCLUSION COMPLEXES WITH CYCLODEXTRINS (SOLUBILIZERS/STABILIZERS) AND ACID-ADDITION SALTS OF DRUGS (CODEINE) AND A FATTY/BILE ACID FARMARC NEDERLAND B.V. (NL) 2001-07-03 — — US disclosed
EP-1024833-A1 Pharmaceutical composition containing acid addition salt of basic drug FARMARC NEDERLAND B.V. (NL) 2000-08-09 — — EP disclosed
WO-1998002187-A1 PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG FARMARC NEDERLAND B.V. (NL) 1998-01-22 — — WO disclosed
Send feedback